Med-Pharmex, Inc
FDA inspection history in Pomona, California, 2019 to 2023
- 3
- Form 483s
Every document, by year
- Form 483
2019: one Form 483; 2021: one Form 483; 2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2019–23Three Form 483s, at Pomona, California.
- 2021The longest 483 on file: 13 observations over 20 pages at Pomona, California.
Cited most
Across all Med-Pharmex observations on file
- 21 CFR 211.160General requirements4
- 21 CFR 211.165Testing and release for distribution4
- 21 CFR 514.80Records and reports concerning experience with approved new animal drugs3
- 21 CFR 211.100(a)Written procedures; deviations2
- 21 CFR 211.192Production record review2
The complete Med-Pharmex file.
All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Pomona, California
Three Form 483s · 2019 to 2023 · 29 observations
Latest: Form 483, Dec 18, 2023 →
Documents
3 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-12-18 | 483 Form 483 | Pomona, California | 4 | $99 |
| 2021-09-14 | 483 Form 483 | Pomona, California | 13 | $99 |
| 2019-05-17 | 483 Form 483 | Pomona, California | 12 | $99 |
Investigators on these documents
Walden H. Lee (3)Christopher R. Czajka (1)Uttaniti Limchumroon (1)
FEI number 2023614 · most recent document Dec 18, 2023
About Med-Pharmex, Inc
How many FDA Form 483s has Med-Pharmex, Inc received?
FDA Intel has 3 Form 483s on file for Med-Pharmex, Inc; the most recent is dated Dec 18, 2023.
When was Med-Pharmex, Inc last inspected by FDA?
The most recent FDA inspection document on file for Med-Pharmex, Inc is a Form 483 dated Dec 18, 2023, for the site in Pomona, California.
What did FDA cite at Med-Pharmex, Inc?
The regulations cited most in the observations on file for Med-Pharmex, Inc are 21 CFR 211.160 (General requirements), 4 times; 21 CFR 211.165 (Testing and release for distribution), 4 times; 21 CFR 514.80 (Records and reports concerning experience with approved new animal drugs), 3 times.